ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Developmental Environmental Chronotoxicity by Polystyrene Nanoplastics Exacerbates High-Fat Diet-Induced Pediatric MAFLD Through Circadian Disruption and Mitochondrial Dysfunction.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Environmental nanoplastic exposure is increasingly recognized as a contributor to metabolic dysfunction, yet its impact on susceptibility to diet-induced metabolic dysfunction-associated fatty liver disease (MAFLD) during development remains unclear. Here, we show that polystyrene nanoplastics (PS-NPs) exacerbate high-fat diet (HFD)-induced hepatic steatosis in an age-dependent manner. In juvenile, but not adult, mice, PS-NPs augmented HFD-driven dyslipidemia, hepatomegaly, and hepatic lipid accumulation without altering energy intake. Mechanistic analyses revealed disruption of the hepatic circadian-mitochondrial axis, including altered clock gene programs, impaired AMP-activated protein kinase (AMPK) signaling, mitochondrial dysfunction, and suppressed oxidative metabolism. In hepatocytes, PS-NPs potentiated free-fatty-acid-induced circadian misalignment, mitochondrial impairment, oxidative stress, and lipid accumulation. AMPK activation by AICAR alleviated steatosis and mitochondrial defects, whereas circadian modulation by SR9009 improved mitochondrial function and hepatocellular injury, highlighting distinct protective mechanisms. Collectively, these findings define early life as a critical window of vulnerability to combined environmental and dietary stressors and introduce the concept of chronotoxicity, the capacity of environmental exposures, such as PS-NPs, to perturb circadian timing and temporal metabolic organization-linking nanoplastic exposure to pediatric MAFLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.